Reporting Mechanisms for Conflict of Interest Disclosures in Medicine Need Standardization
ASCO officials examined the discrepancies in financial disclosures across platforms and call for a simplified system.
Skin Cancer
SKIN CANCER ADVISOR
FEATURED CONTENT
-
-
Popular Genetic Tests Miss Many Cancer-Associated Genetic Variants, Particularly in Ethnic Minorities
The chance of missing a disease-causing variant can be as high as 100% across some groups. -
Immune Checkpoint Inhibitors on Track for Better Personalization
Emerging evidence suggests that a better understanding of T-cell behavior may help immune checkpoint inhibitors become more personalized. -
Nivolumab Plus Ipilimumab in Advanced Melanoma Improves Survival at 5-Year Follow-Up — but Significant Toxicities Linger
A phase 3 trial looking at nivolumab and ipilimumab in advanced melanoma has reported increased survival with the combination, but notable toxicities. -
Soluble PD-1 Is a Potential Biomarker in Metastatic Melanoma in Patients Treated With Autologous Vaccines
A small study on patients with metastatic melanoma who were treated with autologous vaccines in a phase 2 clinical trial suggests that soluble PD-1 may have potential as a prognostic biomarker.
VIDEO SERIES
Recent Advances in Melanoma Therapy
Targeted Treatments and Immunotherapies for Melanoma
Tailoring Treatments in Melanoma
Drug Resistance in Melanoma
Affordability of Melanoma Care
Melanoma: Treatment-induced Toxicity
Immunotherapy: A Decade of Improvements in Melanoma
Should Patients With Melanoma Receive Targeted Therapy or Immunotherapy First?
Melanoma: Checkpoints in the Pipeline
Targeting Therapy for Melanoma Subtypes
Melanoma: Targetable Genes in the Pipeline
Clinical Trials in Melanoma
SKIN CANCER NEWS
Satisfaction High With Mohs Surgery for Melanoma In Situ
Permanent Chemotherapy-Induced Alopecia: Study Reveals Knowledge and Practice Gaps Occur Across Multiple Disciplines
Therapeutic, Survival Outcomes in Advanced Malignant Melanoma Influenced by Facility Volume
Eosinophilic Fasciitis: A Rare Immune-Related Adverse Effect of Immune Checkpoint Inhibitor Therapy
Incidence of Squamous Cell Carcinoma of the Anus Increasing
Want to read more?
Please login or register first to view this content.
